First documented cure of a suggestive exogenous reinfection in polymyositis with same but multidrug resistant M. tuberculosis

BMC Infectious Diseases

Volumn 4, Issue , 2004, Pages

  Mukhopadhyay, Chiranjoy ^a,b   Garg, Ankita ^a   Ayyagari, Archana ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSERINE; ETHAMBUTOL; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; KANAMYCIN; METHOTREXATE; PYRAZINAMIDE; RIFAMPICIN; SPARFLOXACIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT; BACTERIAL PROTEIN; DEVR PROTEIN, NOSTOC; PRIMER DNA; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CASE REPORT; CLINICAL FEATURE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LYMPH NODE; MALE; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MILIARY TUBERCULOSIS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NECK; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMYOSITIS; REINFECTION; SKIN ABSCESS; SKIN TUBERCULOSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TREATMENT PLANNING; ABSCESS; BACTERIAL SKIN DISEASE; CHEMISTRY; CLASSIFICATION; DRUG EFFECT; GENETICS; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; POLYMERASE CHAIN REACTION; RECURRENT DISEASE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ABSCESS; ADULT; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DNA PRIMERS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMYOSITIS; RECURRENCE; SKIN DISEASES, BACTERIAL; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, MILIARY;

EID: 25444517757     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-4-63     Document Type: Article

References (22)

1. Chadha VK: Epidemiological Situation of Tuberculosis in India. J Indian Med Assoc 2003, 3:144-147.
2. Meltzer MS, Nacy CA: Cutaneous Tuberculosis. eMedicine [http://www.emedicine.com/derm/topic434.htm]. Last updated: April 22, 2003
3. Chin PW, Koh CK, Wong KT: Cutaneous tuberculosis mimicking cellulites in an immunosuppressed patient. Singapore Med J 1999, 40:44-45.
4. WHO/IUATLD Global Working Group on Antitubercular Drug Resistance Surveillance: Guidelines for surveillance of drug resistance in tuberculosis. In Int J Tuber Lung Dis Volume 2. WHO Geneva/ IUATLD, Paris; 1998:72-89.
5. Singh KK, Nair MD, Radhakrishnan K, Tyagi JS: Utility of PCR assay in diagnosis of en-plaque tuberculoma of the brain. J Clin Microbiol 1999, 37:467-470.
6. Kremer K, van Soolingen D, Frothingham R, Haas WH, Hermans PWM, Martín C, Palittapongarnpim P, Plikaytis BB, Riley LW, Yakrus MA, Musser JM, van Embden JDA: Comparison of Methods Based on Different Molecular Epidemiological Markers for Typing of Mycobacterium tuberculosis Complex Strains: Interlaboratory Study of Discriminatory Power and Reproducibility. J Clin Microbiol 1999, 37:2607-2618.
7. Park K: Tuberculosis. In In Park's textbook of Preventive and Social Medicine 17th edition. M/s Banarsidas Bhanot, 1167, Prem Nagar, Jabalpur-482001 India; 2002:138-153.
8. World Health Organization: Weekly Epidemiological Record No. 12 2002:2.
9. Warren RM, Victor TC, Streicher EM, Richardson M, Beyers N, van Pittius NC, van Helden PD: Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care Med 2004, 169:610-614.
10. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, Beyers N, van Helden PD: Exogenous Reinfection as a cause of recurrent tuberculosis after curative treatment. New Eng J Med 1999, 341:1174-1179.
11. Braden CR, Morlock GP, Woodley CL, Johnson KR, Colombet AC, Cave MD, Yang Z, Valway SE, Onorato IM, Crawford JT: Simultaneous infection with multiple strains of Mycobacterium tuberculosis. Clin Infect Dis 2001, 33:e42-47.
12. Sahadevan R, Narayanan S, Paramasivan CN, Prabhakar R, Narayanan PR: Restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, India, by use of direct-repeat probe. J Clin Microbiol 1995, 33:3037-3039.
13. Das S, Chan SL, Allen BW, Mitchison DA, Lowrie DB: Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy. Tuber Lung Dis 1993, 74:47-51.
14. Van Rie A, Warren R, Richardson M, Gie RP, Enarson DA, Beyers N, van Helden PD: Classification of drug-resistant tuberculosis in an epidemic area. Lancet 2000, 356:22-25.
15. Hindler J: Modified proportion agar dilution test for slowly growing mycobacteria. In In Antimicrobial susceptibility testing Volume 1. Edited by: Isenberg HD. Clinical Microbiology Procedures Handbook. American Society for Microbiology. Washington, D.C; 1992:1-15.
16. Vincent V, Brown-Elliott BA, Jost KC, Wallace RJ: Mycobacterium: Phenotypic and genotypic identification. In In Manual of Clinical Microbiology Volume 1. 8th edition. Edited by: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH. New York; 2003:560-584.
17. O'Brien JR: Non-reactive tuberculosis. J Clin Pathol 1954, 7:216-225.
18. Salazman SH, Schindel ML, Aranda CP, Smith RL, Lewis ML: The role of bronchoscopy in the diagnosis of pulmonary tuberculosis in patients at risk for HIV infection. Chest 1992, 102:143-146.
19. Fujita M, Arakawa K, Mizuno S, Wakabayashi M, Totani Y, Demura Y, Ameshima S, Miyamori I, Ishizaki T, Sawai T: A Case of Cutaneous Tuberculosis Under Steroid & Immunosuppressant Therapy for Dermatomyositis (In Japanese). Kekkaku (Tuberculosis) 2002, 77:465-470.
20. Berg J, Leonard A, Clancy CJ, Nguyen MH: Subcutaneous abscesses due to Mycobacterium tuberculosis: Paradoxical expansion of disease during therapy for miliary tuberculosis. Clin Infect Dis 1998, 26:231-232.
21. Crofton J, Chaulet P, Maher D: Guidelines for the management of drug-resistant tuberculosis. WHO/TB/96.210 1996:39.
22. Crofton J, Chaulet P, Maher D: Guidelines for the management of drug-resistant tuberculosis. WHO/TB/96.210 1996:41-42.